-
公开(公告)号:WO2008124878A1
公开(公告)日:2008-10-23
申请号:PCT/AU2008/000519
申请日:2008-04-14
Applicant: CRYPTOPHARMA PTY LTD , STEWART, Alastair , BANWELL, Martin , LEUNG, Brenda , AUGUSTINE, Anu , KITCHING, Jacki , BILSKI, Tomasz
Inventor: STEWART, Alastair , BANWELL, Martin , LEUNG, Brenda , AUGUSTINE, Anu , KITCHING, Jacki , BILSKI, Tomasz
IPC: C07C15/12 , C07C13/465 , C07C205/20 , A61K31/015 , C07C13/48 , C07C251/32 , A61K31/025 , C07C13/66 , C07C251/52 , A61K31/04 , C07C22/06 , C07C251/54 , A61K31/15 , C07C25/18 , C07C251/56 , A61K31/36 , C07C39/18 , C07C251/86 , A61K31/365 , C07C39/21 , C07D231/56 , A61K31/416 , C07C39/23 , C07D271/12 , A61P11/06 , C07C39/373 , C07D317/50 , A61P43/00 , C07C205/06 , C07J41/00 , C07C13/19 , C07C205/11
CPC classification number: C07C45/68 , C07C45/298 , C07C45/30 , C07C45/59 , C07C45/63 , C07C45/673 , C07C45/71 , C07C47/575 , C07C49/753 , C07C49/84 , C07C251/32 , C07C251/52 , C07C251/54 , C07C251/56 , C07C251/86 , C07D231/56 , C07D271/12 , C07D317/58
Abstract: The present invention relates to non-steroidal compounds useful in the treatment of inflammatory conditions and pharmaceutical compositions comprising them. A representative example of these compounds is formula (III).
Abstract translation: 本发明涉及用于治疗炎性病症的非甾体化合物和包含它们的药物组合物。 这些化合物的代表性实例是式(III)。
-
公开(公告)号:WO1997042958A1
公开(公告)日:1997-11-20
申请号:PCT/AU1997000286
申请日:1997-05-09
Applicant: AMRAD OPERATIONS PTY. LTD. , STEWART, Alastair, George
Inventor: AMRAD OPERATIONS PTY. LTD.
IPC: A61K31/56
CPC classification number: A61K31/566 , A61K31/565 , Y10S514/826
Abstract: The invention relates to use of steroids or steroid analogues in the treatment of chronic and acute inflammation of the airways, particularly asthmatic conditions. It also relates to compounds and compositions which modulate airway remodelling. In a preferred embodiment, the steroid is 2-methoxyoestradiol.
Abstract translation: 本发明涉及类固醇或类固醇类似物在治疗气道的慢性和急性炎症,特别是哮喘病症中的应用。 它还涉及调节气道重塑的化合物和组合物。 在优选的实施方案中,类固醇是2-甲氧基雌二醇。
-
公开(公告)号:WO2008109936A1
公开(公告)日:2008-09-18
申请号:PCT/AU2008/000325
申请日:2008-03-07
Applicant: CRYPTOPHARMA PTY LTD , STEWART, Alastair , BANWELL, Martin , LEUNG, Brenda , AUGUSTINE, Anu
Inventor: STEWART, Alastair , BANWELL, Martin , LEUNG, Brenda , AUGUSTINE, Anu
CPC classification number: A61K8/63
Abstract: The present invention provides a compound of Formula I, pharmaceutical compositions and methods of use thereof.
Abstract translation: 本发明提供式I的化合物,药物组合物及其使用方法。
-
公开(公告)号:WO2004101595A1
公开(公告)日:2004-11-25
申请号:PCT/AU2004/000630
申请日:2004-05-13
Applicant: CRYPTOPHARMA PTY LTD , MCALLISTER, David, James , LAMBERT, John, Nicholas , STEWART, Alastair, George
Inventor: STEWART, Alastair, George
IPC: C07J41/00
CPC classification number: C07J41/00 , C07J43/00 , Y02P20/582
Abstract: Compounds and methods for modulating mesenchymal cell function, for instance smooth muscle and fibroblast proliferation or cytokine expression, and for treating conditions associated with mesenchymal cell function, for instance airway hyperresponsiveness associated with asthma. The compounds also supress inflammation. The compounds are a class of estratriene derivates, and includes various derivatives of 2-methoxyestradiol comprising a group A, including a substituted aromatic substituent in the 2-, 6- or 17- position.
Abstract translation: 用于调节间充质细胞功能的化合物和方法,例如平滑肌和成纤维细胞增殖或细胞因子表达,以及用于治疗与间充质细胞功能相关的病症,例如与哮喘相关的气道高反应性。 这些化合物也能抑制炎症。 该化合物是一类雌三烯衍生物,并且包括包含A组的2-甲氧基雌二醇的各种衍生物,包括在2-,6-或17-位的取代的芳族取代基。
-
-
-